Our medical weight-loss treatments feature GLP-1based therapies that gently mirror a natural hormone responsible for regulating appetite, slowing digestion, and enhancing satietycreating a more effortless, harmonious approach to weight management
Zhang QY, et al
Malnutrition is a dangerous complication in cirrhotic patients that should be avoided at all costs, as it is associated with many dangerous outcomes, including sepsis, uncontrolled ascites, Hepatic encephalopathy, spontaneous bacterial peritonitis, and Hepatorenal syndrome
Related guides The Complete GLP-1 Agonist List: Every FDA-Approved and Compounded Option Explained by Mechanism, Dosing, and Clinical Use GLP-1 Agonist List of Drugs: The Complete Guide to Every FDA-Approved and Compounded Option in 2026 GLP-1 Brands: Every FDA-Approved and Compounded Option Compared (2026 Complete Guide) Complete GLP-1 RA Drugs List: Every FDA-Approved and Compounded Option in 2026 The Complete GLP-1 Medication List: Every FDA-Approved and Compounded Option in 2026 What Is the Brand Name for Tirzepatide
10.1016/j.lfs.2010.10.025 Life Sci
Plaintiffs claim manufacturers: Knew or should have known gastroparesis could be permanent Failed to adequately warn patients and doctors Understated the severity and duration of risk Continued aggressive marketing despite safety signals 2
